TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29524976

Group type: EXPERIMENTAL
Intervention: Fluoroless-URS
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard-URS
Number of subjects: 154
Study: 26670912

Group type: EXPERIMENTAL
Intervention: Personalised text message reminder (including first name and contact information)
Number of subjects: 539

Group type: COMPARATOR
Intervention: Generic text message reminder
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Personalised text message reminder for patients with recent chlamydia
Number of subjects: 539

Group type: COMPARATOR
Intervention: Generic text message reminder for patients with recent chlamydia
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Personalised text message reminder for patients with recent gonorrhoea
Number of subjects: 539

Group type: COMPARATOR
Intervention: Generic text message reminder for patients with recent gonorrhoea
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Personalised text message reminder for MSM
Number of subjects: 539

Group type: COMPARATOR
Intervention: Generic text message reminder for MSM
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Personalised text message reminder
Number of subjects: 539
Study: 24528942

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg twice daily
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 22566415

Group type: EXPERIMENTAL
Intervention: Reminder/recall (2 letters and 2 telephone calls)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 800
Study: 20627749

Group type: EXPERIMENTAL
Intervention: Pleural tenting
Number of subjects: 48

Group type: COMPARATOR
Intervention: No tenting (Control)
Number of subjects: 48
Study: 19149363

Group type: EXPERIMENTAL
Intervention: Chili group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 50
Study: 15735115

Group type: EXPERIMENTAL
Intervention: Medial tumors
Number of subjects: 8422

Group type: EXPERIMENTAL
Intervention: Medial tumors (node-negative cohort)
Number of subjects: 8422
Study: 12877895

Group type: EXPERIMENTAL
Intervention: BCT (Blood Cell Transplantation)
Number of subjects: 101

Group type: COMPARATOR
Intervention: BMT (Bone Marrow Transplantation)
Number of subjects: 101
Study: 10587385

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy with urokinase using the pulse‐spray technique (ENDO)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Surgical thrombectomy with or without graft revision (SURG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both ENDO and SURG groups
Number of subjects: 80
Study: 8692739

Group type: EXPERIMENTAL
Intervention: Intravenous montelukast sodium (3, 9, and 18 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral montelukast sodium (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous montelukast sodium (9 mg) in females
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral montelukast sodium (10 mg) in females
Number of subjects: 12
Study: 1919803

Group type: EXPERIMENTAL
Intervention: 500 mg of vitamin C daily
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ferric ammonium citrate (FeAC; equivalent to 6 mg iron) plus vitamin C for 9 weeks
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Aerobic exercise at 50% VO2 max
Number of subjects: 54
Study: 6627292

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Nitrazepam (5 mg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 30638739

Group type: EXPERIMENTAL
Intervention: Four-oil lipid emulsion (30% soybean oil, 30% medium-chain triglycerides, 25% olive oil, 15% fish oil) administered continuously for 5 days, FO dose of 0.09-0.22 g/kg body weight.
Number of subjects: 75

Group type: COMPARATOR
Intervention: 100% soybean oil lipid emulsion administered continuously for 5 days.
Number of subjects: 75

Group type: COMPARATOR
Intervention: Four-oil lipid emulsion (SG) vs 100% soybean oil (CG)
Number of subjects: 75
Study: 30680401

Group type: EXPERIMENTAL
Intervention: SPR periodontal basic treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no specific treatment mentioned)
Number of subjects: 80
Study: 26768855

Group type: EXPERIMENTAL
Intervention: Daily Transcranial Doppler (TCD) measurements
Number of subjects: 89

Group type: COMPARATOR
Intervention: No Transcranial Doppler (TCD) measurements
Number of subjects: 89
Study: 26075751

Group type: EXPERIMENTAL
Intervention: Choice of diet (low-carbohydrate diet [LCD] or low-fat diet [LFD]) with counseling for 48 weeks
Number of subjects: 207

Group type: COMPARATOR
Intervention: Random assignment to a diet (LCD or LFD) with counseling for 48 weeks
Number of subjects: 207
Study: 22136963

Group type: EXPERIMENTAL
Intervention: Intravenous lipid emulsion containing eicosapentaenoic and docosahexaenoic acid
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no lipid emulsion with eicosapentaenoic and docosahexaenoic acid)
Number of subjects: 32
Study: 20617588

Group type: EXPERIMENTAL
Intervention: Human serum immunoglobulin 400 mg/(kg x d) infusion qd for 7 days
Number of subjects: 220

Group type: COMPARATOR
Intervention: Prednisolone tablets 1 mg/(kg x d), 2 times/d for 2 weeks, then gradually reducing; all-trans retinoic acid 10 mg, 3 times a day, oral
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Human serum immunoglobulin treatment
Number of subjects: 220
Study: 18765182

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with physiotherapy (Group-1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Acupuncture alone (Group-2)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Physiotherapy alone (Group-3)
Number of subjects: 46
Study: 15692600

Group type: EXPERIMENTAL
Intervention: Angiotensin-I-converting enzyme inhibitors (ACEI), n=25 (15%)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Non-ACEI group, n=143 (85%)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Patients with hypertension taking ACEI
Number of subjects: 168

Group type: COMPARATOR
Intervention: Patients with hypertension not taking ACEI
Number of subjects: 168
Study: 11833075

Group type: EXPERIMENTAL
Intervention: High-dose iodized oil TACE (more than 20 mL Lipiodol)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Routine dose iodized oil TACE (5-15 mL Lipiodol)
Number of subjects: 473
Study: 10362425

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide at doses of < or =5 ppm
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Prolonged inhaled nitric oxide at doses of < or =20 ppm
Number of subjects: 26
Study: 7722713

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (specifics on dosage and duration not available)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Nutritional supplementation
Number of subjects: 356
Study: 2040466

Group type: EXPERIMENTAL
Intervention: Cisapride (10 mg) three times a day for three days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 6389470

Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir (5 mg/kg three times daily for five days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral acyclovir (400 mg five times daily for five days)
Number of subjects: 40
Study: 31302066

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Occlusal splint and botulinum toxin injections
Number of subjects: 73

Group type: COMPARATOR
Intervention: Occlusal splint
Number of subjects: 73
Study: 29787484

Group type: EXPERIMENTAL
Intervention: Vergence‐accommodative therapy (n = 4)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo therapy (n = 3)
Number of subjects: 7
Study: 27281233

Group type: EXPERIMENTAL
Intervention: Vacuum sealing drainage (VSD) and antibiotic‐loaded bone cement
Number of subjects: 46

Group type: COMPARATOR
Intervention: Vacuum sealing drainage (VSD) only
Number of subjects: 46
Study: 24932979

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine plus 0.5 M mannitol (2.90 mL solution: 1.84 mL lidocaine with 18.4 μg epinephrine + 1.06 mL mannitol)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control: Lidocaine with epinephrine (1.84 mL solution: 36.8 mg lidocaine with 18.4 μg epinephrine)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine plus 0.5 M mannitol
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control: Lidocaine with epinephrine
Number of subjects: 41
Study: 22227226

Group type: EXPERIMENTAL
Intervention: robenacoxib (2 mg/kg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: meloxicam (0.3 mg/kg)
Number of subjects: 96
Study: 20541324

Group type: EXPERIMENTAL
Intervention: High pressure group (20‐25 mmHg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low pressure group (10‐15 mmHg)
Number of subjects: 17
Study: 20064644

Group type: EXPERIMENTAL
Intervention: Observational learning with a model present
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ghost condition (no model present)
Number of subjects: 20
Study: 15642076

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 505

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 505
Study: 12097664

Group type: EXPERIMENTAL
Intervention: High amylose cornstarch (AM) diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Standard cornstarch (AP) diet
Number of subjects: 24
Study: 9741192

Group type: EXPERIMENTAL
Intervention: Mastopathy patients (group M)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Healthy women (group K)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Postmenopausal patients with mastopathy
Number of subjects: 65
Study: 7799476

Group type: EXPERIMENTAL
Intervention: Sodium citrate (0.5 g kg‐1 body mass)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (1 g of calcium carbonate and 4 mg of sodium chloride)
Number of subjects: 8
Study: 2899186

Group type: EXPERIMENTAL
Intervention: Pimozide
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of pimozide and lithium
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 31957542

Group type: EXPERIMENTAL
Intervention: Auditory cues with clear audio
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Visual cues with clear audio
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Visual cues with incongruent auditory information
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Degraded audio conditions
Number of subjects: 10
Study: 29427725

Group type: EXPERIMENTAL
Intervention: 12-week knee extensor strengthening exercise program
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 97
Study: 30650290

Group type: EXPERIMENTAL
Intervention: Guishen Zhiyang Recipe (GZR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fuyang Granule (FG)
Number of subjects: 90
Study: 24848384

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine infusion (6 μg/kg/minute)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 60
Study: 23731195

Group type: EXPERIMENTAL
Intervention: Active formulation containing licochalcone A, l-carnitine and 1,2-decanediol applied twice daily for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vehicle applied twice daily for 8 weeks
Number of subjects: 60
Study: 20008943

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI) or venlafaxine, with or without cognitive-behavioral therapy (CBT)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: FKBP5 genotypes (rs1360780TT and rs3800373GG)
Number of subjects: 155
Study: 18171951

Group type: EXPERIMENTAL
Intervention: Computer-assisted minimally invasive total knee arthroplasty
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 108
Study: 15732619

Group type: EXPERIMENTAL
Intervention: Iron-rich spa water (Spatone)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 102
Study: 12632268

Group type: EXPERIMENTAL
Intervention: Minimal invasive aortic surgery (MIAS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard open aortic procedures
Number of subjects: 80
Study: 10818263

Group type: EXPERIMENTAL
Intervention: NPY 50 microg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NPY 100 microg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NPY (both doses)
Number of subjects: 20
Study: 8815021

Group type: EXPERIMENTAL
Intervention: Cefuroxim 1500 mg administered 30 min before the procedure (Group A, n = 49)
Number of subjects: 99

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (Group B, n = 50)
Number of subjects: 99
Study: 1814657

Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 6441721

Group type: COMPARATOR
Intervention: Vasoactive intestinal polypeptide (VIP) infusion in controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vasoactive intestinal polypeptide (VIP) infusion in hyperprolactinaemics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bromocriptine pretreatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethazone pretreatment
Number of subjects: 0
Study: 31256116

Group type: EXPERIMENTAL
Intervention: WESIHAT 2.0© (30 minutes per day, 4 days per week for six months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Health education pamphlets (control group)
Number of subjects: 50
Study: 29122965

Group type: EXPERIMENTAL
Intervention: 20 g of dairy protein supplementation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 27112273

Group type: EXPERIMENTAL
Intervention: Individualized risk assessment leaflet
Number of subjects: 960

Group type: COMPARATOR
Intervention: Standardized leaflet with general information
Number of subjects: 960
Study: 24240607

Group type: EXPERIMENTAL
Intervention: Rifaximin, administered in cycles of 7-10 days per month over a period of 3 months
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 1003
Study: 22321770

Group type: EXPERIMENTAL
Intervention: Fidaxomicin (200 mg every 12 h for 10 days)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Vancomycin (125 mg every 6 h for 10 days)
Number of subjects: 509
Study: 20072053

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) strength training for 4 weeks, 20 minutes per session, 4 sessions per week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no ES training)
Number of subjects: 20
Study: 17912636

Group type: EXPERIMENTAL
Intervention: Letrozole monotherapy
Number of subjects: 8010

Group type: COMPARATOR
Intervention: Tamoxifen monotherapy
Number of subjects: 8010
Study: 16053194

Group type: EXPERIMENTAL
Intervention: 14 days of ceftriaxone
Number of subjects: 201

Group type: COMPARATOR
Intervention: 28 days of ceftriaxone
Number of subjects: 201
Study: 12572098

Group type: EXPERIMENTAL
Intervention: Mandibular overdenture on two implants (IMP-group)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Conventional complete denture (VP-group)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Complete denture after preprosthetic surgery (MVP-group)
Number of subjects: 149
Study: 10347961

Group type: EXPERIMENTAL
Intervention: Beclomethasone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Inhalatory corticosteroids therapy with educational program (EDUCASMA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 8562152

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with LV (200 mg/m2) plus 5‐FU (350 mg/m2), both given i.v. (days 1‐4) and i.p. (days 1 and 3) every 4 weeks for a total of six courses
Number of subjects: 121

Group type: COMPARATOR
Intervention: Observation (standard care)
Number of subjects: 121
Study: 2527993

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 824924

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of fat emulsion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no fat emulsion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholecystectomized patients after fat infusion
Number of subjects: 0
Study: 31964118

Group type: EXPERIMENTAL
Intervention: Lidocaine (6 mL of 2% lidocaine)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Saline (6 mL of saline)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Non-rehydrated packs
Number of subjects: 75
Study: 30339737

Group type: EXPERIMENTAL
Intervention: Nerve hydrodissection with 5-ml normal saline injection
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (normal saline injection)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Nerve hydrodissection
Number of subjects: 34
Study: 28115299

Group type: EXPERIMENTAL
Intervention: Interactive web-based intervention
Number of subjects: 1041

Group type: COMPARATOR
Intervention: Plain-text web-based intervention
Number of subjects: 1041

Group type: EXPERIMENTAL
Intervention: Both interventions (interactive and plain-text)
Number of subjects: 1041
Study: 25666468

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Frequent goal‐based monitoring with pharmacotherapy
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Education and support
Number of subjects: 1609
Study: 23337416

Group type: EXPERIMENTAL
Intervention: TOF <0.9 group
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (TOF ≥0.9)
Number of subjects: 149
Study: 21358389

Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC) for 2 hours per week
Number of subjects: 112

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Escitalopram and Health Education (HE)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 112
Study: 19538921

Group type: EXPERIMENTAL
Intervention: Brief intervention sessions founded in motivational interviewing techniques (2 sessions)
Number of subjects: 363
Study: 17516709

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 0
Study: 15479202

Group type: EXPERIMENTAL
Intervention: Prevention model (use of hand alcohol and gloves)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular model (use of soap and water)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular model (use of gloves)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prevention model (use of gloves)
Number of subjects: 0
Study: 11500348

Group type: EXPERIMENTAL
Intervention: Albuterol (n = 28)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 41
Study: 9332625

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 8398021

Group type: EXPERIMENTAL
Intervention: Conventional TENS
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Acupuncture‐like TENS
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Forearm skin temperature
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Ring finger skin temperature
Number of subjects: 31
Study: 3536526

Group type: EXPERIMENTAL
Intervention: Halsted radical mastectomy (n 349)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Quadrantectomy with axillary dissection and radiotherapy (n 352)
Number of subjects: 701
Study: 30376904

Group type: EXPERIMENTAL
Intervention: Sensationalized media exposure
Number of subjects: 102

Group type: COMPARATOR
Intervention: Non-sensationalized media exposure
Number of subjects: 102
Study: 29768525

Group type: EXPERIMENTAL
Intervention: Milk supplemented with Lactobacillus rhamnosus 5x10^6 and Bifidobacterium longum 3x10^6 (intervention group)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Standard milk (control group)
Number of subjects: 363
Study: 27285856

Group type: EXPERIMENTAL
Intervention: MSB11022
Number of subjects: 237

Group type: COMPARATOR
Intervention: US-RP
Number of subjects: 237

Group type: COMPARATOR
Intervention: EU-RMP
Number of subjects: 237
Study: 24165376

Group type: EXPERIMENTAL
Intervention: Counseled group (25 couples)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (24 couples)
Number of subjects: 74
Study: 22137256

Group type: EXPERIMENTAL
Intervention: EPA-rich oil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: DHA-rich oil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EPA-rich oil (males)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: DHA-rich oil (females)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21055511

Group type: EXPERIMENTAL
Intervention: Fetoscopic selective laser coagulation (FSLC)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 128
Study: 17988947

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 514

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 514
Study: 16333385

Group type: EXPERIMENTAL
Intervention: Conventional three dose scheme (month 0, 1, 6)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Two dose brief scheme (month 0, 1)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Three dose brief scheme (month 0, 1, 2)
Number of subjects: 89
Study: 12882862

Group type: EXPERIMENTAL
Intervention: Preprandial insulin aspart (immediately before meal start)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Postprandial insulin aspart (immediately after a meal or a maximum of 30 min after meal start)
Number of subjects: 76
Study: 11213533

Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 8636580

Group type: EXPERIMENTAL
Intervention: Participants in the randomized trial
Number of subjects: 7191

Group type: COMPARATOR
Intervention: Nonparticipants
Number of subjects: 7191
Study: 1377307

Group type: EXPERIMENTAL
Intervention: Slow-release verapamil (240 mg once daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nitrendipine (20 mg once daily)
Number of subjects: 20
Study: 6383268

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no prophylactic antibiotics)
Number of subjects: 105